NASA’s Cassini spacecraft has sent back some images of Atlas, an atypical...
British pharmaceuticals giant GlaxoSmithKline (GSK) has announced a voluntary recall for more than 590,000 albuterol inhalers because of a potential issue with their delivery system.
Juan Carlos Molina, a spokesperson for GSK, told reporters that three lots of Ventolin HFA 200D inhalers, with lot numbers 6ZP0003, 6ZP9944 and 6ZP9848, were being recalled due the potential risk.
Confirming the recall, Molina said, “There is possible risk that the affected inhalers could potentially not deliver the stated number of actuations. We continue to investigate the issue in order to identify the root cause and implement appropriate corrective and preventative actions.”
Like any other metered-dose inhalers, albuterol inhalers deliver a fixed dose of medication in the form of aerosol into the body of the patient through the airway and lungs.
An improperly functioning inhaler can release unpredictable, risky dose of medication in the patient’s body.
It isn’t a patient-level recall, but any patient whose inhaler might be among the affected lots can contact the company’s customer service center at 1-888-825-5249. If case of any emergency, patients should immediately seek professional medical treatment.
Whether you want to ask us a question, would like to solve a problem, or just give us a suggestion, you’ll find many ways to contact us right here.
Email: [email protected]
Phone: (916) 225-9835
Fax: (916) 225-9845
Researchers at the Harvard-Smithsonian Center for...
South Korea-based electronics giant Samsung has just...